BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Cases. Sep 16, 2026; 14(26): 126744
Published online Sep 16, 2026. doi: 10.12998/wjcc.126744
Table 3 Etiologic evaluation of acute liver failure and limitations of retrospective causality assessment
Etiologic category
Investigation or exposure
Available result/documentation
Interpretation or limitation
Viral hepatitisViral hepatitis investigationDocumented as negative in the medical recordThe contemporaneous medical record documented negative viral hepatitis testing; individual viral assays, numerical results, methods, and testing dates were unavailable for independent retrospective verification
Autoimmune liver diseaseAutoimmune liver-disease investigationDocumented as negative in the medical recordThe medical record documented a negative autoimmune liver-disease investigation; individual autoantibodies, immunoglobulin results, methods, and testing dates were unavailable for independent retrospective verification
Wilson diseaseWilson disease evaluationDocumented as investigated and excludedWilson disease was documented as investigated and excluded; the individual diagnostic tests, numerical results, methods, and dates were unavailable for independent retrospective verification
HemochromatosisHemochromatosis evaluationDocumented as investigated and excludedHemochromatosis was documented as investigated and excluded; the individual diagnostic tests, numerical results, methods, and dates were unavailable for independent retrospective verification
Additional viral testingHEV, HSV, EBV, and CMV testingDocumented as investigated/negative in the medical recordThe original individual assay results, methods, and testing dates were unavailable for independent retrospective verification
Drug or toxin exposureAcetaminophen, alcohol, illicit/recreational drugs, and other medications or supplementsPatient denied acetaminophen use, alcohol consumption, and illicit/recreational drug use; no additional medications or supplements were reported beyond omeprazole and P. major infusionNo competing exposure was identified from the documented history other than omeprazole. A serum acetaminophen concentration and formal toxicology screening results were not available for retrospective verification
Competing medicationOmeprazoleDocumented exposureThe exact dose and exposure dates were unavailable; omeprazole was retained as a competing exposure
Herbal exposureP. major infusionApproximately 2 L/day for 15 consecutive daysThis represents prepared infusion volume only. Botanical authentication, quantified botanical dose, chemical analysis, and contamination testing were not available
RechallengeRe-exposure to P. majorNot performedNo rechallenge occurred
DechallengeBiochemical course after cessationNot interpretableLiver transplantation occurred before biochemical recovery, preventing interpretation of a conventional dechallenge course


Write to the Help Desk